Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tianzhuo Wang

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Iscience|January 21, 2022
Heterogeneity of intrinsic plasticity in cerebellar Purkinje cells linked with cortical molecular zonesNguyen-Minh Viet, Tianzhuo Wang, Khoa Tran-Anh, et al.
Scientific Reports|February 7, 2025
Study on scour simulation and boundary condition conversion technology for a shallow foundation bridgeGangping Fan, Huanzhe Li, Tianzhuo Wang, et al.
Journal of Clinical Medicine|January 11, 2024
A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal CancerJiayun Zou, Yuanyuan Wang, Jiayu Xu, et al.
Cancer Letters|April 15, 2018
HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progressionJiagui Song, Tianzhuo Wang, Weizhi Xu, et al.
American Journal of Clinical Oncology|December 18, 2023
Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysisMingqiang Shi, Zhoujuan Li, Tianzhuo Wang, et al.
Frontiers of Medicine|April 15, 2023
FERM domain-containing protein FRMD6 activates the mTOR signaling pathway and promotes lung cancer progressionTianzhuo Wang, Huiying Guo, Lei Zhang, et al.
Current Cancer Drug Targets|April 7, 2023
Second-line Endocrine Therapy of Hormone Receptor-positive/HER2- negative Advanced Breast Cancer: A Systematic Review and Network Meta-analysisTianzhuo Wang, Guoshuang Shen, Jinming Li, et al.
Cell Death & Disease|December 22, 2025
Targeting intrinsically disordered nuclear protein 1 (NUPR1) with single-domain antibodies alleviates triple-negative breast cancer (TNBC) progression in vivoTianzhuo Wang, Min Wang, Xuanru Chen, et al.
Cancer Pathogenesis and Therapy|April 11, 2024
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysisMingqiang Shi, Zhoujuan Li, Guoshuang Shen, et al.
Frontiers in Oncology|March 9, 2023
Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysisXingfa Huo, Guoshuang Shen, Tianzhuo Wang, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Iscience|January 21, 2022
Heterogeneity of intrinsic plasticity in cerebellar Purkinje cells linked with cortical molecular zonesNguyen-Minh Viet, Tianzhuo Wang, Khoa Tran-Anh, et al.
Scientific Reports|February 7, 2025
Study on scour simulation and boundary condition conversion technology for a shallow foundation bridgeGangping Fan, Huanzhe Li, Tianzhuo Wang, et al.
Journal of Clinical Medicine|January 11, 2024
A Retrospective Study of Trifluridine/Tipiracil with Fruquintinib in Patients with Chemorefractory Metastatic Colorectal CancerJiayun Zou, Yuanyuan Wang, Jiayu Xu, et al.
Cancer Letters|April 15, 2018
HOXB9 acetylation at K27 is responsible for its suppression of colon cancer progressionJiagui Song, Tianzhuo Wang, Weizhi Xu, et al.
American Journal of Clinical Oncology|December 18, 2023
Third-line Treatment for Metastatic Triple-negative Breast Cancer: A Systematic Review and Network Meta-analysisMingqiang Shi, Zhoujuan Li, Tianzhuo Wang, et al.
Frontiers of Medicine|April 15, 2023
FERM domain-containing protein FRMD6 activates the mTOR signaling pathway and promotes lung cancer progressionTianzhuo Wang, Huiying Guo, Lei Zhang, et al.
Current Cancer Drug Targets|April 7, 2023
Second-line Endocrine Therapy of Hormone Receptor-positive/HER2- negative Advanced Breast Cancer: A Systematic Review and Network Meta-analysisTianzhuo Wang, Guoshuang Shen, Jinming Li, et al.
Cell Death & Disease|December 22, 2025
Targeting intrinsically disordered nuclear protein 1 (NUPR1) with single-domain antibodies alleviates triple-negative breast cancer (TNBC) progression in vivoTianzhuo Wang, Min Wang, Xuanru Chen, et al.
Cancer Pathogenesis and Therapy|April 11, 2024
Efficacy and safety of first-line treatment for metastatic triple-negative breast cancer: A network meta-analysisMingqiang Shi, Zhoujuan Li, Guoshuang Shen, et al.
Frontiers in Oncology|March 9, 2023
Treatment options for patients with human epidermal growth factor 2-positive breast cancer brain metastases: A systematic review and meta-analysisXingfa Huo, Guoshuang Shen, Tianzhuo Wang, et al.
Pageof 2